𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The historical development of interferons as multiple sclerosis therapies

✍ Scribed by Kenneth P. Johnson

Publisher
Springer
Year
1997
Tongue
English
Weight
50 KB
Volume
75
Category
Article
ISSN
0946-2716

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Toward the development of rational thera
Toward the development of rational therapies in multiple sclerosis: what is on the horizon?
✍ Bernhard Hemmer; Hans-Peter Hartung πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 343 KB πŸ‘ 2 views

## Abstract Although the cause of multiple sclerosis (MS) has remained obscure, many findings support an autoimmune pathogenesis on the background of a complex interaction between multiple genes and environmental factors. Accordingly, targeting the immune system has been a rational approach for the

Real-life impact of early interferonΞ² th
Real-life impact of early interferonΞ² therapy in relapsing multiple sclerosis
✍ M. Trojano; F. Pellegrini; D. Paolicelli; A. Fuiani; G.B. Zimatore; C. Tortorell πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 207 KB πŸ‘ 1 views

## Abstract ## Objective Recent findings support greater efficacy of early vs. delayed interferon beta (IFNΞ²) treatment in patients with a first clinical event suggestive of multiple sclerosis (MS). We aimed to evaluate the effectiveness of early IFNΞ² treatment in definite relapsing‐remitting MS (